Loading...
Market
Which regulatory body will first approve 'Liquid Gold' plasma therapy by end of 2025?
2
Resolution / Starting Odds
FDA (US) • 25%
EMA (European Union) • 25%
MHRA (UK) • 25%
Other • 25%
Official announcements from regulatory bodies such as FDA, EMA, etc.
Story
Billionaire Bryan Johnson Reveals 'Liquid Gold' Plasma Therapy, Reverses Father's Age by 25 Years
Oct 15, 2024, 11:05 AM
Tech millionaire and CEO Bryan Johnson has revealed a new blood exchange therapy, which he refers to as 'liquid gold' plasma. Johnson, who is also a billionaire, claims that this 'super plasma' has reversed his father's age by 25 years. The procedure, known as Total Plasma Exchange, is aimed at removing toxins from the body and is part of Johnson's anti-aging regimen.
View original story
Similar markets
FDA • 33%
EMA • 33%
Both • 34%
FDA (USA) • 25%
EMA (EU) • 25%
MHRA (UK) • 25%
Other • 25%
European Medicines Agency (EMA) • 25%
Medicines and Healthcare products Regulatory Agency (MHRA) • 25%
Therapeutic Goods Administration (TGA) • 25%
Other • 25%
FDA (USA) • 25%
EMA (Europe) • 25%
MHRA (UK) • 25%
Other • 25%
European Central Bank • 25%
BaFin (Germany) • 25%
US SEC • 25%
Other • 25%
Only FDA • 25%
FDA and EMA • 25%
FDA, EMA, and MHRA • 25%
None • 25%
FDA (USA) • 25%
EMA (Europe) • 25%
MHRA (UK) • 25%
Other • 25%
European Medicines Agency (EMA) • 25%
Health Canada • 25%
Japan's PMDA • 25%
Other • 25%
Adaptimmune (Afami-cel) • 25%
Checkpoint Therapeutics (Cosibelimab) • 25%
Mirati Therapeutics (Adagrasib-Cetuximab) • 25%
Other • 25%
FDA only • 25%
EMA only • 25%
Both FDA and EMA • 25%
Neither • 25%
United States • 25%
European Union • 25%
China • 25%
Other • 25%